Skip to main content
Updating results

Pharmacology

  • Updated

WASHINGTON (AP) — Johnson & Johnson’s single-dose vaccine offers strong protection against severe COVID-19, according to an analysis released Wednesday by U.S. regulators that sets the stage for a final decision on a new and easier-to-use shot to help tame the pandemic.

  • Updated

JOHANNESBURG (AP) — South Africa is preparing to give its first COVID-19 vaccinations — shots of the Johnson & Johnson vaccine still being tested — to health care workers this week, the health minister said Tuesday.

  • Updated

NEW YORK (AP) — About 1 in 3 Americans say they definitely or probably won’t get the COVID-19 vaccine, according to a new poll that some experts say is discouraging news if the U.S. hopes to achieve herd immunity and vanquish the outbreak.

  • Updated

GENEVA (AP) — Independent experts advising the World Health Organization about immunization on Wednesday recommended the use of AstraZeneca’s vaccine even in countries that turned up worrying coronavirus variants in their populations.

  • Updated

LONDON (AP) — Britain’s health chief has hailed a new study suggesting that a single dose of the Oxford-AstraZeneca COVID-19 vaccine provides a high level of protection for 12 weeks, saying it supports the government’s contentious strategy of delaying the second shot so it can protect more people quickly with a first dose.

  • Updated

News outlets have been parsing President Joe Biden’s promise of 1 million COVID-19 shots a day for his first 100 days. Depending on the outlet, the goal is too ambitious, or too modest, or doable but difficult, or already stirring disagreements within Biden’s pandemic response team. Only one thing is indisputable: Time will tell. April 30 will mark 100 days since Biden was inaugurated, but ...

Get up-to-the-minute news sent straight to your device.

Topics

Breaking News

News Alert